Uncategorized


October 6, 2025

Capitol Policy Weekly: Government Shutdown, Farmer Aid and Drug Pricing

By Joe Lieber

While the government shutdown is the top issue in Washington this week, we could also expect: 1) positive news out of the White House on aid for farmers, which is likely positive for the farm…

Read More >>

October 1, 2025

Rx Pricing: More Shoes to Drop or Clearing Event?

By John Leppard

The White House’s Rx pricing agreement with PFE yesterday – with the promise of additional company deals next week – may provide industry with some incremental goodwill, but we are dubious that it takes broader…

Read More >>

September 29, 2025

Capitol Policy Weekly: A Government Shutdown, Liquidity, Trade and the NDAA

By Joe Lieber

Two issues are likely to dominate Washington this week: 1) the likelihood of a government shutdown; and 2) the fallout of Trump’s recent trade announcements. Additionally, we expect the Senate to resume consideration of the…

Read More >>

September 29, 2025

Medicare Advantage: CMS’ Stable Message Eclipsed by Falling Enrollment Forecast, But A Wait and See Attitude Is Appropriate

By Beth Steindecker

While reports over the weekend about CMS’s Friday release of the Medicare Advantage (MA) and Part D Plan (PDP) premium, deductible and other information for the 2026 plan year focused on the 2.6% projected cut…

Read More >>

September 26, 2025

Medicare Advantage RADV Audits in Legal Limbo, But Don’t Discount Its Resurrection [HUM, UNH, CVS, CNC, ELV, ALHC]

By Beth Steindecker

Medicare Advantage (MA) insurers [HUM, UNH, CVS, CNC, ELV, ALHC] received some positive legal news that for now neutralizes the concern of widespread Medicare audits and potential concomitant recoupments. However, yesterday’s federal district court ruling…

Read More >>

September 25, 2025

Obamacare Fix: Still Optimistic, But Not Clean or Near Term [OSCR, CNC, HCA, THC, UHS, ACHC]

By Beth Steindecker

We continue to be optimistic and think the odds have risen above 50% that Congress later this year reaches a compromise to “fix” the expiring enhanced Obamacare subsidies, which would further remove some of the…

Read More >>

September 25, 2025

Rx Pricing: MFN Demo Incoming?

By John Leppard

The White House’s Office of Management & Budget’s (OMB) disclosure this morning that it is reviewing what appears to be a Most Favored Nation (MFN) drug pricing model is consistent with our long-held expectations, if…

Read More >>

September 22, 2025

DC Quick Takes: Govt. Shutdown, NDAA, Durbin 2.0 (V, MA), Interest on Fed Reserves (JPM, C, BAC, WFC), and GAIN AI Act (NVDA, AMD)

By Joe Lieber

We continue to believe that the odds of a government shutdown are at least 75%, though that might be too low given that Congress is out of session this week. The Senate is scheduled back…

Read More >>

September 18, 2025

Odds and Impacts of a Government Shutdown

By Joe Lieber

We are bumping our odds to ~75% (up from 65%) that a government shutdown occurs on Oct. 1. This is partially in light of the Democrats’ funding proposal, which includes:   A continuing resolution (CR) funding…

Read More >>

September 15, 2025

Capitol Policy Weekly: Government Shutdown/Funding, NDAA, Healthcare, and the HIRE Act

By Joe Lieber

Both chambers of Congress are in session this week before a scheduled recess next week for Rosh Hashana, though we suspect that break will be cut short given the need to avoid a government shutdown…

Read More >>